Roadzen Delivers Best Quarter in Company History with Q4 FY2026 Revenue of $16.1 Million, Up 42% Year-Over-Year; Record Full-Year Revenue of $55.0 Million, Up 24%
Rhea-AI Summary
Roadzen (Nasdaq: RDZN) reported its best quarter, with Q4 FY2026 revenue of $16.1 million, up 42% year-over-year and 12% sequentially. Full-year revenue reached a record $55.0 million, up 24%. Net loss narrowed 69% to $22.5 million, while full-year Adjusted EBITDA loss improved to $(3.5) million.
Operating expenses fell 34%, gross margin rose to 61.3%, and Q4 marked a seventh consecutive Adjusted EBITDA improvement. Roadzen reduced short-term debt by about 60%, extended a $11.5 million facility to 2027, completed EliteCover and VehicleCare acquisitions, and entered FY2027 with over $30 million in new annual revenue commitments.
Positive
- Q4 FY2026 revenue $16.1 million, up 42% year-over-year and 12% sequentially
- Full-year FY2026 revenue $55.0 million, up 24% from $44.3 million
- FY2026 net loss reduced 69% to $22.5 million, or $0.29 per share
- Adjusted EBITDA loss improved to $3.5 million from $8.4 million in FY2025
- Gross margin increased to 61.3% from 57.5% year-over-year
- Total operating expenses cut 34% to $69.0 million
- Short-term borrowings reduced about 60%, from $19.9 million to $7.8 million
- Cash and equivalents increased to $6.6 million from $4.8 million
- Extension of $11.5 million senior secured Mizuho facility to July 2027
- Roadzen exited FY2026 at roughly $64 million annualized revenue run-rate
- Over $30 million in new annual revenue commitments secured in Q1 FY2027
- EliteCover acquisition opens access to ~$80 billion U.S. commercial auto market
- VehicleCare acquisition valued India subsidiary at $277 million
- VehicleCare mandates expected to generate over $20 million in annual revenue
- Roadzen brokerage achieved $25.2 million quarterly GWP, building toward $100 million annualized
- Achieved first ‘Rule of 40’ quarter in two years
- Adjusted EBITDA margin improved from -10.2% to -3.3% between FY2026 halves
Negative
- FY2026 net loss remains $22.5 million despite improvement
- Q4 FY2026 net loss was $7.3 million, or $0.09 per share
- Adjusted EBITDA still negative at $3.5 million loss for FY2026
- Total liabilities $79.2 million exceed total assets of $52.7 million
- Long-term borrowings increased to $15.6 million
- Convertible notes outstanding total $13.2 million
- Ordinary shares outstanding rose to 79.7 million, about 7% dilution
News Market Reaction – RDZN
In the Jun 29 session, RDZN declined 3.75%, reflecting a moderate negative market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 26 | Full-year results | Positive | +2.8% | FY2025 results showed net loss collapse and improving efficiency despite prior U.K. disruption. |
| Feb 12 | Quarterly results | Positive | +15.5% | Q3 FY2025 loss narrowed sharply and EBITDA improved with better gross margin and lower expenses. |
| Nov 13 | Quarterly results | Neutral | -4.0% | Q2 FY2025 revenue rebounded sequentially but losses remained large despite EBITDA progress. |
| Aug 13 | Quarterly results | Positive | -10.3% | Q1 FY2025 delivered strong growth in revenue and policies but with a sizable net loss. |
| Jul 01 | Full-year results | Positive | +82.1% | First year as public company showed rapid revenue growth despite heavy non-cash-driven losses. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have often triggered strong upside moves for RDZN, though there are occasional selloffs despite broadly positive operational updates.
Key Terms
adjusted ebitda financial
combined ratio financial
convertible notes financial
senior secured facility financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Roadzen Posts First ‘Rule of 40’ Quarter in Two Years; FY2026 Net Loss Narrows
- Record Revenue Growth Drives Strongest Quarter in Company History
Roadzen delivered record fourth-quarter revenue of$16.1 million , up42% year-over-year and12% sequentially — the highest quarterly revenue in Company history. Full-year FY2026 revenue rose to a record$55.0 million , up24% from$44.3 million in FY2025, reflecting sustained multi-quarter acceleration driven by rising customer adoption and expanding enterprise penetration. - Net Loss Narrows Sharply; Adjusted EBITDA1 Approaches Break-Even
Net loss attributable to ordinary shareholders for FY2026 fell approximately69% to$(22.5) million , or$(0.29) per share, from$(72.9) million , or$(1.04) per share, in FY2025, and full-year operating loss improved77% to$(14.0) million from$(60.8) million in FY2025. Adjusted EBITDA loss for the fourth quarter was$(0.4) million , compared to$(1.6) million in the prior-year quarter, and full-year Adjusted EBITDA loss improved to$(3.5) million from$(8.4) million in FY2025 — Roadzen's seventh consecutive quarter of improvement. - Scaled AI Platform Delivers Measurable Ecosystem Impact
Roadzen's AI platform processes over 3 million insurance claims annually and leverages over 4 billion miles of proprietary real-world driving data to power precision underwriting, claims automation, telematics, and driver intelligence. The platform delivers up to72% accident reduction for fleets. Roadzen's MGA operations run at an average85% combined ratio — compared to an industry average of approximately103% — and claims-to-repair cycle times are cut from an average of ~6 weeks to 48 hours for standard repairs, strengthened by VehicleCare. - FY2027 Momentum Builds; Profitability Path Defined
Roadzen exited FY2026 at an approximately$64 million annualized revenue run-rate. With over$30 million in new annual revenue commitments already secured in Q1 FY2027 — across insurance contracts, OEM partnerships, fleet deployments, and carrier capacity programs — the Company has clear visibility towards reaching a$100 million annualized revenue run-rate and positive Adjusted EBITDA for the coming fiscal year.
_______________________
1 Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.
NEW YORK, June 29, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN) ("Roadzen" or the "Company"), a global leader in AI at the convergence of insurance and mobility, today announced its financial results for the Fiscal 2026 fourth quarter and full year ended March 31, 2026.
Commenting on the Company's results, Rohan Malhotra, Founder and CEO of Roadzen, stated, "This was the best quarter in our history. We have been building towards this growth for two years by laying the groundwork — we are seeing increased adoption of our platform, largely driven by the U.S. and India, and democratic growth across all of our product lines. More customers are adopting more of our platform, across more geographies, and at increasing speed.
We are showcasing real-world AI at scale. Unlike general intelligence models, which are large, expensive and general-purpose, our focus is on building specialized models that deliver enterprise intelligence within context — that are built for precision and the lowest cost of delivery, so that our accuracy translates directly into real economic impact for our customers. As adoption grows, the network effects across our data, distribution, and decisioning compound.
Our goal for this year is clear: to be one of a handful of AI companies, globally, with over
Roadzen's CFO, Jean-Noël Gallardo, commented, "The Fiscal fourth quarter represented a clear acceleration in Roadzen's financial trajectory, with record quarterly revenue growing
There is clear momentum in the operating performance of the business, where year-over-year revenue growth has accelerated from an average of
We also made decisive improvements to our balance sheet. We reduced short-term borrowings by approximately
Fourth Quarter and Full Year Financial Highlights
P&L
Revenue and Key Performance Indicators:
- Revenue for the Fourth Quarter ended March 31, 2026, increased to
$16.1 million , compared to$11.3 million in the prior year period, representing42% year-over-year growth, and increased12% sequentially from$14.4 million in Q3 FY2026, marking the highest quarterly revenue in Company history. Growth was driven by continued expansion across insurance, mobility, and AI-powered fleet intelligence solutions, supported by increasing enterprise adoption and scaling deployments globally. - Revenue for the Fiscal Year ended March 31, 2026, increased to
$55.0 million , compared to$44.3 million in FY2025, representing24% year-over-year growth. Gross margin for the fourth quarter was consistent with the prior year at65.7% . For the full fiscal year, gross margin increased to61.3% versus57.5% in FY2025, demonstrating underlying operating leverage as the Company scales its AI-powered insurance and mobility platform. - As of March 31, 2026, Roadzen had 61 insurance customer agreements (including carriers, self-insureds and other entities processing insurance claims), 91 automotive customer agreements, and approximately 4,200 agents and fleet customer agreements. This compares to 61 insurance, 87 automotive and 4,100 agent and fleet customers as of December 31, 2025.
- Roadzen brokerage business sold 144,270 policies during the fourth quarter for approximately
$25.2 million of Gross Written Premium ("GWP"), compared to 149,810 policies in the prior FY2026 third quarter, producing$17.1 million of GWP. Crossing$25 million in quarterly Gross Written Premium is an important milestone for the Company as it builds toward$100 million in annualized GWP — driven by continued growth in India alongside a rising contribution from the U.S., where higher average premiums per policy and stronger margins are increasingly accretive to the mix. - In our IaaS business, 1,409,790 claims, roadside assistance and vehicle inspections were conducted during the three months ending March 31, 2026, compared to 1,397,535 for the prior third quarter ending December 31, 2025.
Net Results:
- Net loss attributable to ordinary shareholders for the Fiscal Year ended March 31, 2026, was
$(22.5) million , or$(0.29) per share, compared to$(72.9) million , or$(1.04) per share, in FY2025, representing a significant year-over-year improvement driven by materially lower operating losses and stronger revenue scaling across the Company's AI-powered insurance and mobility platform. Of the FY2026 net loss, approximately$9.8 million was comprised of non-cash expenses, including a$4.0 million loss on fair value of the Company's financial instruments (convertible notes, variable instruments and warrants),$2.2 million related to depreciation and amortization, and$3.6 million related to other non-cash items. - Total operating expenses for the Fiscal Year ended March 31, 2026, were
$69.0 million , compared to$105.1 million in FY2025, representing a34% year-over-year reduction, driven by significant decreases in corporate overhead and general and administrative expenses, partially offset by higher cost of services reflecting increased platform utilization and revenue scaling. - Adjusted EBITDA loss for the fiscal year was
$(3.5) million , compared to$(8.4) million in FY2025. Fourth Quarter Adjusted EBITDA loss was$(0.4) million , compared to$(1.6) million in the prior-year quarter and$(0.6) million in the sequential third quarter, marking Roadzen's seventh consecutive quarter of sequential improvement.
Balance Sheet
Assets:
- Total assets as of March 31, 2026, were
$52.7 million , an increase of$20.1 million from the previous Fiscal Year end, driven by growth in receivables, acquisition-related intangible assets, and equity raised during the year. The Company ended the year with cash and cash equivalents of$6.6 million compared to$4.8 million at the prior year end period.
Liabilities:
- Total liabilities as of March 31, 2026, were
$79.2 million , compared to$58.3 million at Fiscal Year-end 2025. These include$13.2 million of convertible notes and$4.2 million of non-cash liabilities, which is comprised of$2.0 million of derivative warrant liability,$1.0 million of deferred tax liability, and$1.2 million related to deferred revenue and retirement benefits. - During the Fiscal Year, Roadzen restructured its debt profile to establish a more stable, longer-duration capital structure. The Company reduced short-term borrowings by approximately
60% , from$19.9 million to$7.8 million , while extending into long-term borrowings, which grew to$15.6 million . This deliberate shift strengthened Roadzen’s near-term liquidity and capital flexibility, positioning the balance sheet to support continued growth — including the extension of the Company's$11.5 million senior secured facility with Mizuho Securities USA LLC to July 2027.
Capitalization:
- As of March 31, 2026, the Company had approximately 79.7 million Ordinary Shares outstanding, an increase of 5.4 million shares from the prior fiscal year-end. This represented dilution of only approximately
7% to shareholders, as Roadzen raised a meaningful portion of its growth capital through its India subsidiary at a premium to the Nasdaq share price, limiting the absolute impact to the Company's stock; Roadzen India was valued at$277 million following the VehicleCare acquisition.
drivebuddyAI Developments:
- Patent — Driver Identification: drivebuddyAI was granted a patent for AI-powered in-vehicle facial recognition enabling continuous driver identification, anchoring AI-driven risk scoring, fatigue detection, and compliance enforcement to verified driver identity in real time.
- Patent — Hazardous Road Condition Detection: drivebuddyAI was granted a patent for AI-based detection and geo-mapping of hazardous road conditions in real time.
- Patent — Real-Time Lane Detection: drivebuddyAI was granted a patent for its AI-powered Real-Time Lane Detection System, a core technology underpinning advanced driver assistance and autonomous driving systems.
- These awards expand drivebuddyAI’s IP portfolio to more than 15 patents and reinforce its technological edge as the only platform certified under AIS-184, EU GSR 2144, and Euro NCAP 2026 standards.
- Surpassed 4 billion miles of real-world driving data, demonstrating up to
72% accident reduction.
Acquisitions: Strategic Acquisitions Unlock New Markets and Full-Stack Control
- EliteCover Insurance — Entry into the ~
$80 Billion U.S. Commercial Auto Insurance Market
On December 3, 2025, Roadzen acquired majority control of EliteCover, a U.S.-based licensed commercial auto insurance broker and Managing General Underwriter operating in California, Texas, Illinois, and New Jersey, with Lloyd's of London Coverholder status. The acquisition provides Roadzen with a regulated underwriting and distribution platform to participate directly in the approximately$80 billion U.S. commercial auto insurance market. Combined with Roadzen's AI-powered underwriting, telematics-driven risk management, automated claims, and integrated roadside assistance through National Automobile Club, EliteCover enables an end-to-end commercial auto insurance offering on a commission- and fee-based model. The synergies created by integrating EliteCover into the Roadzen platform are expected to drive its growth across the U.S. commercial auto market. - VehicleCare — Full-Stack Motor Claims Control
On January 6, 2026, Roadzen agreed to acquire VehicleCare, an AI-powered vehicle repair and workshop aggregation platform. VehicleCare's software-enabled network of more than 1,200 workshops across India allows Roadzen to directly manage repair timelines, quality and cost outcomes, delivering over30% loss-cost reductions versus OEM garages while improving cycle times, transparency, and fraud control. The transaction valued Roadzen's India subsidiary at approximately$277 million , implying a value of roughly$3.50 per Roadzen share, based on Roadzen's ownership of approximately92% of the India subsidiary. Since closing, Roadzen has brought new business to VehicleCare by connecting it to the Company's AI, insurer relationships, and claims funnel — winning two major insurer mandates that are expected to generate more than$20 million in combined annual revenue, and entering into a strategic partnership with TEMOT International, one of the world's largest automotive parts distribution networks, strengthening the infrastructure supporting Roadzen's newly launched 48-hour claims repair turnaround program.
FY2027 – Off to a Strong Start with Over
Financial Developments
- As previously announced, on May 5, 2026, the Company closed on a securities purchase agreement with institutional investors securing
$8 million at an offering price of$1.70 per share. - Roadzen secured an agreement with Mizuho Securities USA LLC to extend the maturity of its
$11.5 million senior secured debt facility to July 7, 2027.
Revenue & Commercial Deployments:
- April 14, 2026 – Roadzen partnered with a top-10 global carmaker to deliver GAP insurance across the U.K., its second major European OEM win since September 2025.
- April 22, 2026 – Roadzen's U.K. subsidiary, Global Insurance Management, secured several new contracts totaling
$2.5 million in projected annual revenue. - April 27, 2026 – Leveraging Roadzen's insurer relationships, VehicleCare secured a major claims mandate from one of India's largest insurers, expected to generate over
$10 million in annual revenue. - April 29, 2026 – Roadzen's drivebuddyAI won a
$2.5 million contract to bring AI-powered safety to a 3,000-truck fleet. - April 30, 2026 – Roadzen secured an LOI for a
$30 million insurance capacity commitment from a leading U.S. carrier, with the program anticipated to contribute approximately$6 million in annual revenue. - June 16, 2026 – Building on Roadzen's distribution, VehicleCare secured a second major insurer mandate with one of India's top 10 general insurers, expected to generate more than
$10 million in annual revenue. - June 18, 2026 – Roadzen expanded its U.S. footprint with a commercial contract valued at approximately
$1.2 million in annual revenue, naming its National Automobile Club subsidiary as the exclusive roadside assistance provider for a digital platform serving more than 500,000 users. - June 23, 2026 – Roadzen's drivebuddyAI secured a
$5.3 million purchase order from one of India's leading EV fleet operators to deploy its AI-powered fleet safety platform across up to 3,600 electric commercial vehicles over five years.
Strategic Partnerships & Ecosystem Expansion:
- May 6, 2026 – VehicleCare partnered with global auto-parts network TEMOT International to build integrated claims-to-repair infrastructure and parts availability across India.
- May 7, 2026 – Roadzen selected as a beta-testing partner for Anthropic's Managed Agents platform for enterprise AI deployment.
Other Interest:
- June 26, 2026 – Roadzen was included in the Russell 2000 and 3000 indices in the semi-annual rebalance, following qualification on Russell rank day.
For more information about Roadzen Inc., please visit https://roadzen.ai.
About Roadzen Inc. Roadzen Inc. (Nasdaq: RDZN) is a global leader in AI at the convergence of insurance and mobility. Roadzen builds technology that helps insurers, automakers, and fleets better predict and prevent risk, automate claims, and deliver seamless, embedded insurance experiences. Thousands of clients across North America, Europe, and Asia — from the world's leading insurers, carmakers, and fleets to dealerships and agents — use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. Roadzen's pioneering work in telematics, generative AI, and computer vision has earned recognition from Forbes, Fortune, and Financial Express as one of the world's top AI innovators. Headquartered in Burlingame, California, Roadzen employs more than 450 people across offices in the U.S., U.K., India, and China. Learn more at www.roadzen.ai.
Cautionary Statement Regarding Forward Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "should," "could," "would," "expect," "plan," "anticipate," "believe," "estimate," and "continue," or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding the anticipated benefits of our products and solutions, our expected revenue growth and anticipated Adjusted EBITDA breakeven timing, expected revenue and results from announced contracts and strategic partnerships, the anticipated synergies and growth from our acquisitions, strategy, demand for our products, expansion plans, future operations, future operating results, estimated revenues, losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in "Risk Factors" in our Securities and Exchange Commission ("SEC") filings, including the annual report on Form 10-K we filed with the SEC on June 26, 2025. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact: Investor Contacts: IR@roadzen.ai Media Contacts: Sanya Soni sanya@roadzen.ai or media@roadzen.ai
Financial Statements Follow
| Roadzen Inc. | ||||
| Consolidated Balance Sheets | ||||
| (in US $, except share count) | ||||
| Particulars | ||||
| As of March 31, 2026 | As of March 31, 2025 | |||
| Assets | ||||
| Current assets: | ||||
| Cash and cash equivalents | 6,578,594 | 4,836,576 | ||
| Accounts receivable, net | 7,500,439 | 2,625,385 | ||
| Inventories | 116,555 | 202,535 | ||
| Prepayments and other current assets | 17,833,119 | 19,092,595 | ||
| Investments | 229,994 | 197,805 | ||
| Total current assets | 32,258,701 | 26,954,896 | ||
| Non current assets | ||||
| Restricted cash | 222,026 | 217,064 | ||
| Non marketable securities | - | 269,470 | ||
| Property and equipment, net | 536,997 | 602,923 | ||
| Goodwill | 7,616,973 | 2,061,553 | ||
| Operating lease right-of-use assets | 1,374,147 | 1,109,219 | ||
| Intangible assets, net | 9,651,915 | 1,243,253 | ||
| Other long-term assets | 997,802 | 120,972 | ||
| Total Non current assets | 20,399,860 | 5,624,454 | ||
| Total assets | 52,658,561 | 32,579,350 | ||
| Liabilities and shareholders' Equity/(Deficit) | ||||
| Current liabilities | ||||
| Current portion of long-term borrowings | 9,829,713 | 2,904,444 | ||
| Short-term borrowings | 7,843,267 | 19,865,645 | ||
| Accounts payable and accrued expenses | 30,245,947 | 30,254,010 | ||
| Derivative warrant liabilities | 1,987,003 | 1,489,818 | ||
| Short-term operating lease liabilities | 325,255 | 318,921 | ||
| Other current liabilities | 8,072,789 | 2,102,466 | ||
| Total current liabilities | 58,303,974 | 56,935,304 | ||
| Non current liabilities | ||||
| Long-term borrowings | 15,612,108 | 139,775 | ||
| Long-term operating lease liabilities | 699,817 | 628,400 | ||
| Other long-term liabilities | 4,561,246 | 566,651 | ||
| Total Non current liabilities | 20,873,171 | 1,334,826 | ||
| Total liabilities | 79,177,145 | 58,270,130 | ||
| Commitments and contingencies (refer note 22) | ||||
| Shareholders' Equity/(Deficit) | ||||
| Ordinary Shares and additional paid in capital, | 112,128,293 | 95,501,291 | ||
| Accumulated deficit | (246,224,660 | ) | (223,826,442 | ) |
| Accumulated other comprehensive income/(loss) | (1,299,868 | ) | (468,859 | ) |
| Other components of equity | 105,747,998 | 103,720,113 | ||
| Total shareholders’ deficit | (29,648,237 | ) | (25,073,897 | ) |
| Non-controlling interest | 3,129,653 | (616,883 | ) | |
| Total deficit | (26,518,584 | ) | (25,690,780 | ) |
| Total liabilities and Total Deficit | 52,658,561 | 32,579,350 | ||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||
| Roadzen Inc. | ||||||||
| Consolidated Statements of Operations | ||||||||
| (in US $, except share count) | ||||||||
| Particulars | For the three months ended March 31, | For the year ended March 31, | ||||||
| 2026 | 2025 | 2026 | 2025 | |||||
| Revenue | 16,121,304 | 11,330,827 | 55,021,792 | 44,296,098 | ||||
| Costs and expenses: | ||||||||
| Cost of services | 5,537,522 | 3,893,120 | 21,277,579 | 18,833,218 | ||||
| Research and development | (115,664 | ) | 244,928 | 408,355 | 3,779,955 | |||
| Sales and marketing | 9,349,677 | 7,133,481 | 29,111,662 | 28,873,150 | ||||
| General and administrative | 6,069,343 | 2,694,733 | 15,976,982 | 51,602,107 | ||||
| Depreciation and amortization | 1,057,462 | 1,046,539 | 2,244,268 | 2,020,610 | ||||
| Total costs and expenses | 21,898,341 | 15,012,801 | 69,018,846 | 105,109,040 | ||||
| Loss from operations | (5,777,037 | ) | (3,681,974 | ) | (13,997,054 | ) | (60,812,942 | ) |
| Interest expense (net) | (1,871,764 | ) | (714,899 | ) | (7,249,803 | ) | (3,247,831 | ) |
| Gain on bargain purchase | 174,248 | — | 174,248 | — | ||||
| Fair value gains/(losses) in financial instruments carried at fair value | 635,187 | 1,681,725 | (3,984,386 | ) | (14,844,420 | ) | ||
| Impairment of investment | (269,470 | ) | (1,245,326 | ) | (269,470 | ) | (1,245,326 | ) |
| Other income (net) | (193,775 | ) | 3,861,541 | 2,329,515 | 7,073,235 | |||
| Total other income/(expense) | (1,525,574 | ) | 3,583,041 | (8,999,896 | ) | (12,264,342 | ) | |
| Loss before income taxes and equity-method investment activity | (7,302,611 | ) | (98,933 | ) | (22,996,950 | ) | (73,077,284 | ) |
| Equity method investment activity, net | — | — | — | — | ||||
| (Loss)/Income before income tax expense | (7,302,611 | ) | (98,933 | ) | (22,996,950 | ) | (73,077,284 | ) |
| Less: income tax (benefit)/expense | (46,966 | ) | 69,709 | 20,212 | (13,973 | ) | ||
| Net (loss)/income before non-controlling interest | (7,255,645 | ) | (168,642 | ) | (23,017,162 | ) | (73,063,311 | ) |
| Net loss attributable to non-controlling interest, net of tax | (1,733 | ) | (61,675 | ) | (500,940 | ) | (192,879 | ) |
| Net Loss attributable to Ordinary shareholders | (7,253,912 | ) | (106,967 | ) | (22,516,222 | ) | (72,870,432 | ) |
| Net loss per share attributable to Ordinary shareholders | ||||||||
| Basic and diluted | (0.09 | ) | (0.00 | ) | (0.29 | ) | (1.04 | ) |
| Weighted-average number of shares used in computing net loss per share | 79,673,597 | 68,882,560 | 77,454,509 | 69,867,792 | ||||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||||||
| RoadzenInc. | ||||
| Unaudited Condensed Consolidated Statements of Cash Flow | ||||
| (in US $, except share count) | ||||
| Particulars | For the year ended March 31, | |||
| 2026 | 2025 | |||
| Cash flows from operating activities | ||||
| Net Loss attributable to Ordinary shareholders | (22,516,222 | ) | (72,870,432 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation and amortization | 2,244,268 | 2,020,610 | ||
| Stock based compensation | 497,806 | 47,211,816 | ||
| Deferred income taxes | (14,303 | ) | (193,261 | ) |
| Unrealised foreign exchange loss/(profit) | (831,009 | ) | 132,121 | |
| Gain over liability settled /expenses settled through issuance of equity equity shares | (64,875 | ) | - | |
| Fair value losses/(profits) in financial instruments carried at fair value | 3,984,386 | 14,844,420 | ||
| Impairment of investment | 269,470 | 1,245,326 | ||
| Expected credit loss (net of reversal) | 2,654,182 | 246,115 | ||
| Assets written off | 82,032 | - | ||
| Balances written off/(back) | (1,545,749 | ) | (8,143,051 | ) |
| Gain on extinguishment of intercompany financial assets and liabilities | (482,689 | ) | - | |
| Net total loss attributable to non-controlling interest, net of tax | (500,940 | ) | (192,879 | ) |
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | ||||
| Inventories | 85,980 | (131,868 | ) | |
| Accounts receivables, net | (4,776,282 | ) | 780,880 | |
| Prepayments and other assets | (3,159,457 | ) | (4,822,952 | ) |
| Accounts payable and accrued expenses | 225,170 | 2,833,077 | ||
| Other liabilities | 3,576,831 | (1,102,120 | ) | |
| Net cash used in operating activities | (20,271,401 | ) | (18,142,198 | ) |
| Cash flows from investing activities | ||||
| Purchase of property and equipment & intangible assets | (1,009,660 | ) | (424,910 | ) |
| Proceeds from sale of mutual fund | 112,847 | 309,289 | ||
| Net cash used in investing activities | (896,813 | ) | (115,621 | ) |
| Cash flows from financing activities | ||||
| Proceeds from issue of ordinary shares | 6,519,429 | 7,073,913 | ||
| Proceeds from issue of equity shares of subsidiary | 6,645,789 | - | ||
| Net proceeds/(payments) from borrowings | 8,279,523 | 3,669,290 | ||
| Proceeds from forward purchase agreement | - | 1,000,000 | ||
| Net cash generated from financing activities | 21,444,741 | 11,743,203 | ||
| Effect of exchange rate changes on cash and cash equivalents | - | 3,168 | ||
| Net (decrease)/increase in cash and cash equivalents (including restricted cash) | 276,527 | (6,511,448 | ) | |
| Cash acquired in business combination | 1,470,453 | - | ||
| Cash and cash equivalents at the beginning of the period (including restricted cash) | 5,053,640 | 11,565,088 | ||
| Cash and cash equivalents at the end of the period (including restricted cash) | 6,800,620 | 5,053,640 | ||
| Reconciliation of cash and cash equivalents | ||||
| Cash and cash equivalents | 6,578,594 | 4,836,576 | ||
| Restricted cash | 222,026 | 217,064 | ||
| Total cash and cash equivalents | 6,800,620 | 5,053,640 | ||
| Supplemental disclosure of cash flow information | ||||
| Cash paid for interest, net of amounts capitalized | 2,742,101 | 1,318,139 | ||
| Non-cash investing and financing activities | ||||
| Consideration payable in connection with acquisitions | 6,407,380 | 8,376,253 | ||
| Interest accrued on borrowings | 3,659,399 | 2,123,633 | ||
| The accompanying notes are an integral part of these consolidated financial statements. | ||||
Non-GAAP Financial Measures This press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (Adjusted EBITDA), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flow provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.
The following tables reconcile our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
| For the three months ended March 31, | Change amount | % | ||||||
| Particulars | 2026 | 2025 | ||||||
| Net loss | (7,253,912 | ) | (106,967 | ) | (7,146,944 | ) | 6681 | % |
| Adjusted for: | ||||||||
| Other (income)/expense net | 193,775 | (3,861,541 | ) | 4,055,316 | -105 | % | ||
| Interest (income)/expense | 1,871,764 | 714,899 | 1,156,865 | 162 | % | |||
| Gain on bargain purchase | (174,248 | ) | - | (174,248 | ) | 100 | % | |
| Fair value changes in financial instruments carried at fair value(1) | (635,187 | ) | (1,681,725 | ) | 1,046,538 | -62 | % | |
| Gain on deconsolidation of subsidiaries | - | - | - | - | ||||
| Impairment of goodwill and intangibles with definite life | - | - | - | - | ||||
| Impairment of investment | - | - | - | - | ||||
| Impairment of investment | 269,470 | 1,245,326 | (975,856 | ) | -78 | % | ||
| Tax (benefit)/expense | (46,966 | ) | 69,709 | (116,675 | ) | -167 | % | |
| Depreciation and amortization | 1,057,462 | 1,046,539 | 10,923 | 1 | % | |||
| Stock based compensation expense | 285,243 | 76,397 | 208,846 | 273 | % | |||
| Non-cash expenses | 2,556,635 | 493,210 | 2,063,425 | 418 | % | |||
| Non-recurring expenses | 1,437,515 | 386,746 | 1,050,769 | 272 | % | |||
| Adjusted EBITDA | (438,449 | ) | (1,617,407 | ) | 1,178,958 | -73 | % | |
| For the year ended March 31, | Change amount | % | ||||||
| Particulars | 2026 | 2025 | ||||||
| Net loss | (22,516,222 | ) | (72,870,432 | ) | 50,354,210 | -69 | % | |
| Adjusted for: | - | - | ||||||
| Other (income)/expense net | (2,329,515 | ) | (7,073,235 | ) | 4,743,720 | -67 | % | |
| Interest (income)/expense | 7,249,803 | 3,247,831 | 4,001,972 | 123 | % | |||
| Gain on bargain purchase | (174,248 | ) | - | (174,248 | ) | 100 | % | |
| Fair value changes in financial instruments carried at fair value(1) | 3,984,386 | 14,844,420 | (10,860,034 | ) | -73 | % | ||
| Gain on deconsolidation of subsidiaries | - | - | - | 100 | % | |||
| Impairment of goodwill and intangibles with definite life | - | - | - | - | ||||
| Impairment of investment | - | - | - | - | ||||
| Impairment of investment | 269,470 | 1,245,326 | (975,856 | ) | -78 | % | ||
| Tax (benefit)/expense | 20,212 | (13,973 | ) | 34,185 | -245 | % | ||
| Depreciation and amortization | 2,244,268 | 2,020,610 | 223,658 | 11 | % | |||
| Stock based compensation expense | 497,806 | 47,211,816 | (46,714,010 | ) | -99 | % | ||
| Non-cash expenses | 2,990,808 | 1,649,448 | 1,341,360 | 81 | % | |||
| Non-recurring expenses | 4,252,368 | 1,340,062 | 2,912,306 | 217 | % | |||
| Adjusted EBITDA | (3,510,864 | ) | (8,398,127 | ) | 4,887,263 | -58 | % | |
(1) Fair value changes in financial instruments are considered to be financing costs as they relate to convertible notes and the Forward Purchase Agreement. These changes are non-cash as these changes in fair value are affected by the volatility of the Company's share price.
